1,695
Views
22
CrossRef citations to date
0
Altmetric
Research Paper

Alterations in the iron homeostasis network: A driving force for macrophage-mediated hepatitis C virus persistency

, , , , , , , & show all
Pages 679-690 | Received 11 Jan 2016, Accepted 01 Apr 2016, Published online: 05 May 2016

References

  • Cho H, Lee HC, Jang SK, Kim YK. Iron increases translation initiation directed by internal ribosome entry site of hepatitis C virus. Virus Genes 2008; 37:154-60; PMID:18566883; http://dx.doi.org/10.1007/s11262-008-0250-0
  • Theurl I, Zoller H, Obrist P, Datz C, Bachmann F, Elliott RM, Weiss G. Iron regulates hepatitis C virus translation via stimulation of expression of translation initiation factor 3. J Infect Dis 2004; 190:819-25; PMID:15272411; http://dx.doi.org/10.1086/422261
  • Bartolomei G, Cevik RE, Marcello A. Modulation of hepatitis C virus replication by iron and hepcidin in Huh7 hepatocytes. J Gen Virol 2011; 92:2072-81; PMID:21593278; http://dx.doi.org/10.1099/vir.0.032706-0
  • Fillebeen C, Pantopoulos K. Iron inhibits replication of infectious hepatitis C virus in permissive Huh7.5.1 cells. J Hepatol 2010; 53:995-9; PMID:20813419; http://dx.doi.org/10.1016/j.jhep.2010.04.044
  • Kakizaki S, Takagi H, Horiguchi N, Toyoda M, Takayama H, Nagamine T, Mori M, Kato N. Iron enhances hepatitis C virus replication in cultured human hepatocytes. Liver 2000; 20:125-8; PMID:10847480; http://dx.doi.org/10.1034/j.1600-0676.2000.020002125.x
  • Fontana RJ, Israel J, LeClair P, Banner BF, Tortorelli K, Grace N, Levine RA, Fiarman G, Thiim M, Tavill AS, et al. Iron reduction before and during interferon therapy of chronic hepatitis C: results of a multicenter, randomized, controlled trial. Hepatology 2000; 31:730-6; PMID:10706565; http://dx.doi.org/10.1002/hep.510310325
  • Steinbicker AU, Muckenthaler MU. Out of balance–systemic iron homeostasis in iron-related disorders. Nutrients 2013; 5:3034-61; PMID:23917168; http://dx.doi.org/10.3390/nu5083034
  • Nemeth E, Tuttle MS, Powelson J, Vaughn MB, Donovan A, Ward DM, Ganz T, Kaplan J. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 2004; 306:2090-3; PMID:15514116; http://dx.doi.org/10.1126/science.1104742
  • Drakesmith H, Nemeth E, Ganz T. Ironing out Ferroportin. Cell Metab 2015; 22:777-87; PMID:26437604; http://dx.doi.org/10.1016/j.cmet.2015.09.006
  • Zhang Z, Zhang F, Guo X, An P, Tao Y, Wang F. Ferroportin1 in hepatocytes and macrophages is required for the efficient mobilization of body iron stores in mice. Hepatology 2012; 56:961-71; PMID:22473803; http://dx.doi.org/10.1002/hep.25746
  • Tai AW, Benita Y, Peng LF, Kim SS, Sakamoto N, Xavier RJ, Chung RT. A functional genomic screen identifies cellular cofactors of hepatitis C virus replication. Cell Host Microbe 2009; 5:298-307; PMID:19286138; http://dx.doi.org/10.1016/j.chom.2009.02.001
  • Girelli D, Pasino M, Goodnough JB, Nemeth E, Guido M, Castagna A, Busti F, Campostrini N, Martinelli N, Vantini I, et al. Reduced serum hepcidin levels in patients with chronic hepatitis C. J Hepatol 2009; 51:845-52; PMID:19729219; http://dx.doi.org/10.1016/j.jhep.2009.06.027
  • Tsochatzis E, Papatheodoridis GV, Koliaraki V, Hadziyannis E, Kafiri G, Manesis EK, Mamalaki A, Archimandritis AJ. Serum hepcidin levels are related to the severity of liver histological lesions in chronic hepatitis C. J Viral Hepat 2010; 17:800-6; PMID:20002304; http://dx.doi.org/10.1111/j.1365-2893.2009.01244.x
  • Miura K, Taura K, Kodama Y, Schnabl B, Brenner DA. Hepatitis C virus-induced oxidative stress suppresses hepcidin expression through increased histone deacetylase activity. Hepatology 2008; 48:1420-9; PMID:18671304; http://dx.doi.org/10.1002/hep.22486
  • Nemeth E, Valore EV, Territo M, Schiller G, Lichtenstein A, Ganz T. Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein. Blood 2003; 101:2461-3; PMID:12433676; http://dx.doi.org/10.1182/blood-2002-10-3235
  • Miyachi H, Kobayashi Y, Relja B, Fujita N, Iwasa M, Gabazza EC, Takei Y. Effect of suppressor of cytokine signaling on hepcidin production in hepatitis C virus replicon cells. Hepatol Res 2011; 41:364-74; PMID:21348906; http://dx.doi.org/10.1111/j.1872-034X.2011.00777.x
  • Koliaraki V, Marinou M, Samiotaki M, Panayotou G, Pantopoulos K, Mamalaki A. Iron regulatory and bactericidal properties of human recombinant hepcidin expressed in Pichia pastoris. Biochimie 2008; 90:726-35; PMID:18295606; http://dx.doi.org/10.1016/j.biochi.2008.01.012
  • Gammella E, Buratti P, Cairo G, Recalcati S. Macrophages: central regulators of iron balance. Metallomics 2014; 6:1336-45; PMID:24905850; http://dx.doi.org/10.1039/C4MT00104D
  • Ponzetto A, Gennero L, Cutufia M, Beltramo T, Enrietto M, Pescarmona P, Pugliese A. Effect of HCV infection on THP-1 monocytoid cells. Cell Biochem Funct 2005; 23:347-52; PMID:15515125; http://dx.doi.org/10.1002/cbf.1158
  • Alvarez-Hernandez X, Felstein MV, Brock JH. The relationship between iron release, ferritin synthesis and intracellular iron distribution in mouse peritoneal macrophages. Evidence for a reduced level of metabolically available iron in elicited macrophages. Biochim Biophys Acta 1986; 886:214-22; PMID:3697381; http://dx.doi.org/10.1016/0167-4889(86)90139-4
  • Zampino R, Marrone A, Restivo L, Guerrera B, Sellitto A, Rinaldi L, Romano C, Adinolfi LE. Chronic HCV infection and inflammation: Clinical impact on hepatic and extra-hepatic manifestations. World J Hepatol 2013; 5:528-40; PMID:24179612; http://dx.doi.org/10.4254/wjh.v5.i10.528
  • Matak P, Chaston TB, Chung B, Srai SK, McKie AT, Sharp PA. Activated macrophages induce hepcidin expression in HuH7 hepatoma cells. Haematologica 2009; 94:773-80; PMID:19454498; http://dx.doi.org/10.3324/haematol.2008.003400
  • Foka P, Dimitriadis A, Kyratzopoulou E, Giannimaras DA, Sarno S, Simos G, Georgopoulou U, Mamalaki A. A complex signaling network involving protein kinase CK2 is required for hepatitis C virus core protein-mediated modulation of the iron-regulatory hepcidin gene expression. Cell Mol Life Sci 2014; 71:4243-58; PMID:24718935; http://dx.doi.org/10.1007/s00018-014-1621-4
  • Sikorska K, Romanowski T, Stalke P, Izycka Swieszewska E, Bielawski KP. Association of hepcidin mRNA expression with hepatocyte iron accumulation and effects of antiviral therapy in chronic hepatitis C infection. Hepat Mon 2014; 14:e21184; PMID:25598789; http://dx.doi.org/10.5812/hepatmon.21184
  • Fillebeen C, Pantopoulos K. Hepatitis C virus infection causes iron deficiency in Huh7.5.1 cells. PLoS One 2013; 8:e83307; PMID:24349485; http://dx.doi.org/10.1371/journal.pone.0083307
  • Liu H, Trinh TL, Dong H, Keith R, Nelson D, Liu C. Iron regulator hepcidin exhibits antiviral activity against hepatitis C virus. PLoS One 2012; 7:e46631; PMID:23110054; http://dx.doi.org/10.1371/journal.pone.0046631
  • Volke M, Gale DP, Maegdefrau U, Schley G, Klanke B, Bosserhoff AK, Maxwell PH, Eckardt KU, Warnecke C. Evidence for a lack of a direct transcriptional suppression of the iron regulatory peptide hepcidin by hypoxia-inducible factors. PLoS One 2009; 4:e7875; PMID:19924283; http://dx.doi.org/10.1371/journal.pone.0007875
  • Chachami G, Lyberopoulou A, Kalousi A, Paraskeva E, Pantopoulos K, Simos G. Oxygen-dependent secretion of a bioactive hepcidin-GFP chimera. Biochem Biophys Res Commun 2013; 435:540-5; PMID:23665013; http://dx.doi.org/10.1016/j.bbrc.2013.04.085
  • Ramey G, Deschemin JC, Durel B, Canonne-Hergaux F, Nicolas G, Vaulont S. Hepcidin targets ferroportin for degradation in hepatocytes. Haematologica 2010; 95:501-4; PMID:19773263; http://dx.doi.org/10.3324/haematol.2009.014399
  • Abboud S, Haile DJ. A novel mammalian iron-regulated protein involved in intracellular iron metabolism. J Biol Chem 2000; 275:19906-12; PMID:10747949; http://dx.doi.org/10.1074/jbc.M000713200
  • Lymboussaki A, Pignatti E, Montosi G, Garuti C, Haile DJ, Pietrangelo A. The role of the iron responsive element in the control of ferroportin1/IREG1/MTP1 gene expression. J Hepatol 2003; 39:710-5; PMID:14568251; http://dx.doi.org/10.1016/S0168-8278(03)00408-2
  • Ward DM, Kaplan J. Ferroportin-mediated iron transport: expression and regulation. Biochim Biophys Acta 2012; 1823:1426-33; PMID:22440327; http://dx.doi.org/10.1016/j.bbamcr.2012.03.004
  • Wang Q, Liu Y, An D, Diao H, Xu W, He X, Sun R, Wei L, Li L. Regulation of hepatitis C virus translation initiation by iron: role of eIF3 and La protein. Virus Res 2012; 167:302-9; PMID:22634302; http://dx.doi.org/10.1016/j.virusres.2012.05.014
  • Fillebeen C, Rivas-Estilla AM, Bisaillon M, Ponka P, Muckenthaler M, Hentze MW, Koromilas AE, Pantopoulos K. Iron inactivates the RNA polymerase NS5B and suppresses subgenomic replication of hepatitis C Virus. J Biol Chem 2005; 280:9049-57; PMID:15637067; http://dx.doi.org/10.1074/jbc.M412687200
  • Theurl I, Theurl M, Seifert M, Mair S, Nairz M, Rumpold H, Zoller H, Bellmann-Weiler R, Niederegger H, Talasz H, et al. Autocrine formation of hepcidin induces iron retention in human monocytes. Blood 2008; 111:2392-9; PMID:18073346; http://dx.doi.org/10.1182/blood-2007-05-090019
  • Kochlios E, Foka P, Mavromara P. Modulation of monocyte/macrophage-derived cytokine and chemokine expression profile by persistent Hepatitis C virus (HCV) infection leads to chronic inflammation. J Mol Biochem 2012; 1:40-53
  • Miki Y, Ono K, Hata S, Suzuki T, Kumamoto H, Sasano H. The advantages of co-culture over mono cell culture in simulating in vivo environment. J Steroid Biochem Mol Biol 2012; 131:68-75; PMID:22265957; http://dx.doi.org/10.1016/j.jsbmb.2011.12.004
  • Andriopoulos B, Pantopoulos K. Hepcidin generated by hepatoma cells inhibits iron export from co-cultured THP1 monocytes. J Hepatol 2006; 44:1125-31. Epub 2005 Dec 5; PMID:16460831; http://dx.doi.org/10.1016/j.jhep.2005.10.025
  • Godoy P, Hewitt NJ, Albrecht U, Andersen ME, Ansari N, Bhattacharya S, Bode JG, Bolleyn J, Borner C, Bottger J, et al. Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME. Arch Toxicol 2013; 87:1315-530; PMID:23974980; http://dx.doi.org/10.1007/s00204-013-1078-5
  • Koskinas J, Tibbs C, Saleh MG, Pereira LM, McFarlane IG, Williams R. Effects of ribavirin on intrahepatic and extrahepatic expression of hepatitis C virus in interferon nonresponsive patients. J Med Virol 1995; 45:29-34; PMID:7714490; http://dx.doi.org/10.1002/jmv.1890450106
  • Pawelczyk A, Kubisa N, Jablonska J, Bukowska-Osko I, Caraballo Cortes K, Fic M, Laskus T, Radkowski M. Detection of hepatitis C virus (HCV) negative strand RNA and NS3 protein in peripheral blood mononuclear cells (PBMC): CD3+, CD14+ and CD19+. Virol J 2013; 10:346; PMID:24279719; http://dx.doi.org/10.1186/1743-422X-10-346
  • Revie D, Salahuddin SZ. Role of macrophages and monocytes in hepatitis C virus infections. World J Gastroenterol 2014; 20:2777-84; PMID:24659871; http://dx.doi.org/10.3748/wjg.v20.i11.2777
  • Radkowski M, Bednarska A, Horban A, Stanczak J, Wilkinson J, Adair DM, Nowicki M, Rakela J, Laskus T. Infection of primary human macrophages with hepatitis C virus in vitro: induction of tumour necrosis factor-alpha and interleukin 8. J Gen Virol 2004; 85:47-59; PMID:14718619; http://dx.doi.org/10.1099/vir.0.19491-0
  • Bare P. Hepatitis C virus and peripheral blood mononuclear cell reservoirs. World J Hepatol 2009; 1:67-71; PMID:21160967; http://dx.doi.org/10.4254/wjh.v1.i1.67
  • Laskus T, Radkowski M, Wilkinson J, Vargas H, Rakela J. The origin of hepatitis C virus reinfecting transplanted livers: serum-derived versus peripheral blood mononuclear cell-derived virus. J Infect Dis 2002; 185:417-21; PMID:11865392; http://dx.doi.org/10.1086/338635
  • Lee WM, Polson JE, Carney DS, Sahin B, Gale M, Jr. Reemergence of hepatitis C virus after 8.5 years in a patient with hypogammaglobulinemia: evidence for an occult viral reservoir. J Infect Dis 2005; 192:1088-92; PMID:16107964; http://dx.doi.org/10.1086/432917
  • Lin A, Thadareddy A, Goldstein MJ, Lake-Bakaar G. Immune suppression leading to hepatitis C virus re-emergence after sustained virological response. J Med Virol 2008; 80:1720-2; PMID:18712814; http://dx.doi.org/10.1002/jmv.21257
  • Parodi C, Garcia G, Monzani MC, Culasso A, Aloisi N, Corti M, Campos R, de EdBMM, Bare P. Hepatitis C virus long-term persistence in peripheral blood mononuclear cells in patients with haemophilia. Detection of occult genotype 1. J Viral Hepat 2015; 22:607-16; PMID:25431170; http://dx.doi.org/10.1111/jvh.12363
  • Sawada K, Masaki N, Hayashi S, Zeniya M, Ishikawa T, Takahashi H, Ohnishi K, Fukunaga K, Hara N, Yamamoto T, et al. Immunomodulatory effects of selective leucocytapheresis as a new adjunct to interferon-alpha2b plus ribavirin combination therapy: a prospective study in patients with high plasma HCV viraemia. J Viral Hepat 2005; 12:274-82; PMID:15850468; http://dx.doi.org/10.1111/j.1365-2893.2005.00577.x
  • Tran TN, Eubanks SK, Schaffer KJ, Zhou CY, Linder MC. Secretion of ferritin by rat hepatoma cells and its regulation by inflammatory cytokines and iron. Blood 1997; 90:4979-86; PMID:9389717
  • Zhang H, Potter BJ. The effect of ethanol metabolism on ferritin uptake by freshly isolated rat hepatocytes: is acetaldehyde responsible for this alteration? Alcohol Clin Exp Res 1992; 16:301-7; PMID:1590551; http://dx.doi.org/10.1111/j.1530-0277.1992.tb01381.x
  • Meyron-Holtz EG, Moshe-Belizowski S, Cohen LA. A possible role for secreted ferritin in tissue iron distribution. J Neural Transm 2011; 118:337-47; PMID:21298454; http://dx.doi.org/10.1007/s00702-011-0582-0
  • Sibille JC, Kondo H, Aisen P. Interactions between isolated hepatocytes and Kupffer cells in iron metabolism: a possible role for ferritin as an iron carrier protein. Hepatology 1988; 8:296-301; PMID:3356411; http://dx.doi.org/10.1002/hep.1840080218
  • Liu Z, He JJ. Cell-cell contact-mediated hepatitis C virus (HCV) transfer, productive infection, and replication and their requirement for HCV receptors. J Virol 2013; 87:8545-58; PMID:23720720; http://dx.doi.org/10.1128/JVI.01062-13
  • Stacey AR, Norris PJ, Qin L, Haygreen EA, Taylor E, Heitman J, Lebedeva M, DeCamp A, Li D, Grove D, et al. Induction of a striking systemic cytokine cascade prior to peak viremia in acute human immunodeficiency virus type 1 infection, in contrast to more modest and delayed responses in acute hepatitis B and C virus infections. J Virol 2009; 83:3719-33; PMID:19176632; http://dx.doi.org/10.1128/JVI.01844-08
  • Fujita N, Sugimoto R, Motonishi S, Tomosugi N, Tanaka H, Takeo M, Iwasa M, Kobayashi Y, Hayashi H, Kaito M, et al. Patients with chronic hepatitis C achieving a sustained virological response to peginterferon and ribavirin therapy recover from impaired hepcidin secretion. J Hepatol 2008; 49:702-10; PMID:18620776; http://dx.doi.org/10.1016/j.jhep.2008.05.014
  • Tsitoura P, Georgopoulou U, Petres S, Varaklioti A, Karafoulidou A, Vagena D, Politis C, Mavromara P. Evidence for cellular uptake of recombinant hepatitis C virus non-enveloped capsid-like particles. FEBS Lett 2007; 581:4049-57; PMID:17678898; http://dx.doi.org/10.1016/j.febslet.2007.07.032
  • Kuiper J, Brouwer A, Knook DL, Van Berkel, TJC. Kupffer and sinusoidal endothelial cells: In The Liver: Biology and Pathobiology. 1994; 3rd edn, 791-818, New York: Raven Press.
  • Foka P, Karamichali E, Dalagiorgou G, Serti E, Doumba PP, Pissas G, Kakkanas A, Kazazi D, Kochlios E, Gaitanou M, et al. Hepatitis C virus modulates lipid regulatory factor Angiopoietin-like 3 gene expression by repressing HNF-1alpha activity. J Hepatol 2014; 60:30-8; PMID:23978712; http://dx.doi.org/10.1016/j.jhep.2013.08.016
  • Steinmann E, Brohm C, Kallis S, Bartenschlager R, Pietschmann T. Efficient trans-encapsidation of hepatitis C virus RNAs into infectious virus-like particles. J Virol 2008; 82:7034-46; PMID:18480457; http://dx.doi.org/10.1128/JVI.00118-08
  • Lohmann, V. HCV replicons: overview and basic protocols. In: Tang H ed. Hepatitis C: Methods and Protocols 510 2nd ed 2009; Humana Press 2009: 145-62

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.